Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.
Petrella F, Rizzo S, Attili I, Passaro A, Zilli T, Martucci F, Bonomo L, Del Grande F, Casiraghi M, De Marinis F, Spaggiari L. Petrella F, et al. Among authors: attili i. Curr Oncol. 2023 Mar 7;30(3):3160-3175. doi: 10.3390/curroncol30030239. Curr Oncol. 2023. PMID: 36975452 Free PMC article. Review.
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.
Frega S, Lorenzi M, Fassan M, Indraccolo S, Calabrese F, Favaretto A, Bonanno L, Polo V, Zago G, Lunardi F, Attili I, Pavan A, Rugge M, Guarneri V, Conte P, Pasello G. Frega S, et al. Among authors: attili i. Oncotarget. 2017 May 16;8(20):32626-32638. doi: 10.18632/oncotarget.15945. Oncotarget. 2017. PMID: 28427238 Free PMC article.
Testing for COVID-19 in lung cancer patients.
Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Passaro A, et al. Among authors: attili i. Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j.annonc.2020.04.002. Epub 2020 Apr 9. Ann Oncol. 2020. PMID: 32278879 Free PMC article. No abstract available.
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer.
Zulato E, Attili I, Pavan A, Nardo G, Del Bianco P, Boscolo Bragadin A, Verza M, Pasqualini L, Pasello G, Fassan M, Calabrese F, Guarneri V, Amadori A, Conte P, Indraccolo S, Bonanno L. Zulato E, et al. Among authors: attili i. Br J Cancer. 2020 Jul;123(1):81-91. doi: 10.1038/s41416-020-0833-7. Epub 2020 May 7. Br J Cancer. 2020. PMID: 32376889 Free PMC article.
erbB in NSCLC as a molecular target: current evidences and future directions.
Del Re M, Cucchiara F, Petrini I, Fogli S, Passaro A, Crucitta S, Attili I, De Marinis F, Chella A, Danesi R. Del Re M, et al. Among authors: attili i. ESMO Open. 2020 Aug;5(4):e000724. doi: 10.1136/esmoopen-2020-000724. ESMO Open. 2020. PMID: 32820012 Free PMC article. Review.
59 results